September 15, 2009 (FinancialWire) — Delcath Systems, Inc. (NASDAQ: DCTH) has appointed David Alan McDonald as its chief financial officer. McDonald was formerly the SVP of business development at AngioDynamics, Inc. (NASDAQ: ANGO).

McDonald founded Minneapolis-based Cornerstone Healthcare Advisors in April 2005, which he led until joining AngioDynamics in July 2008. At Cornerstone he provided advisory and consulting services to emerging medical technology companies and their financial sponsors.

Prior to 2005, McDonald was a managing director at RBC Capital.

The CFO role at Delcath had been vacant since December 2008, when the previous CFO resigned.

New York-based Delcath Systems is a medical device company specializing in cancer treatment. The company is testing a proprietary, patented drug delivery system for the treatment of liver cancers.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.